SARS-CoV-2 evolution during persistent infection in a CAR-T recipient shows an escape to both sotrovimab and T-cell responsesPaola Mazzetti, Mauro Pistello, Pietro Giorgio Spezia et al.|Journal of Clinical Virology Plus|2023Cited by 5